The company, which was established in 2012, focuses on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. Its product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Peijia Medical's operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business. The company is located in Suzhou Industrial Park, which is known as the "new paradise of venture capital investment".